The company seeks to identify, manage and mitigate risks to our business, but uncertainties and risks are difficult to predict and many are outside of the company's control and cannot therefore be eliminated. The company has robust business continuity plans in place across its global supply chain network to help mitigate the impact of covid-19, although these efforts may not completely prevent adverse effects on the business. The company's diversified business model across the healthcare industry is designed with flexibility in its manufacturing, research and development clinical operations and commercial capabilities. The company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers away from high-risk areas to help ensure adequate and effective distribution. The company has established a global vaccine supply network, involving multiple manufacturing sites across different countries and continents, to ensure operational continuity and to meet patient and consumer needs. The company continues to monitor the situation and evaluate both its internal and external supply arrangements, indicating a proactive approach to risk management and operational resilience. The company's high-quality credit rating allows superior access to the financial capital markets, enhancing its financial resilience. The company has a long-standing policy of pricing products responsibly, which reflects its commitment to maintaining organizational health and adaptability in a challenging economic environment. The company strives to maintain profit margins through cost reduction programs, productivity improvements, and periodic price increases, demonstrating its ability to adapt to external pressures. The company’s ability to foresee, confront, and benefit from sudden disruptive change is critical for survival and growth. The company has implemented actions across its global supply chain to enhance agility and drive growth, which includes expanding its use of strategic collaborations and bolstering initiatives to reduce complexity. The company recognizes that the ongoing global economic downturn may impact business operations, and it continues to assess the evolving factors that could affect its financial results. The company’s response to the covid-19 pandemic has highlighted its operational flexibility and commitment to maintaining performance under pressure. The company has invested significantly in research and development to create life-enhancing innovations, reflecting its focus on future planning and strategic foresight. The company’s organizational practices emphasize the importance of recruiting and retaining a diverse workforce, which is essential for fostering innovation and resilience. The company has also established privacy compliance programs and controls to mitigate risks associated with data protection laws, demonstrating its commitment to organizational effectiveness and risk mitigation. The company continues to monitor legislative efforts and economic conditions that may impact its operations, indicating a proactive approach to managing external disturbances and ensuring long-term organizational resilience.